| Absorption |
| Blood-Brain Barrier | BBB- | 0.9653 |
| Human Intestinal Absorption | HIA+ | 0.9839 |
| Caco-2 Permeability | Caco2+ | 0.8866 |
| P-glycoprotein Substrate | Substrate | 0.7862 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8745 |
| Non-inhibitor | 0.7119 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5888 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4041 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8157 |
| CYP450 2D6 Substrate | Non-substrate | 0.8903 |
| CYP450 3A4 Substrate | Non-substrate | 0.6813 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9203 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9214 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9223 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8571 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9369 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6581 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7083 |
| Non-inhibitor | 0.7908 |
| AMES Toxicity | AMES toxic | 0.9108 |
| Carcinogens | Non-carcinogens | 0.9142 |
| Fish Toxicity | High FHMT | 0.9985 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9360 |
| Honey Bee Toxicity | Low HBT | 0.9047 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.8192 |
| Carcinogenicity (Three-class) | Non-required | 0.6148 |